Probiotics\ Ingredients - N°66 les probiotiques? in probiotics? En bref In short les professionnels de santé et le public, et credibility of probiotics in general. Cana- Les investissements contribue à aider les personnes à prendre dian doctors, in collaboration with a team publics et privés soin de leur microbiote. Ce guide est dis- of independent experts, will evaluate the dans l’industrie du ponible pour les États-Unis et le Canada et microbiome sont scientific data backing the products avai- estimés à 1,5 milliard est accessible gratuitement en ligne (http:// lable on the market in the United States and de dollars à ce jour, usprobioticguide.com/). Canada. The purpose of this assessment avec des volumes de transactions importants is to determine the strains and products en Europe, aux Etats- Adozen of research areas are cur-rently being explored in the fieldof probiotics and gut microbiota.supported by studies, as well as the levelof evidence of each indication and targetpopulation. An initiative aimed at creating aUnis, au Canada et enAsie.Public and private During the International Scientific Confe- bridge between research bodies, the health investments in the rence on Probiotics, prebiotics, gut micro- professionals and the public, and at helping microbiome industry are estimated at $1.5 biota and Health (IPC, Budapest, July 2018), people take care of their microbiota. This billion to date, with all these key topics were explored: meta- guide is available for the United States and signifi cant transaction volumes in Europe, the bolic health, skin health, vaginal health, gut Canada and can be accessed for free online United States, Canada health (the relationships between ulcera- (http://usprobioticguide.com/).■ and Asia. tive colitis, the management of diverticular 099 disease, the inhibition of toxin expression), the health-brain axis (protection against stress and anxiety, autism management in children, Alzheimer’s disease), longevity (in animal model for now), prebiotics and probiotics in infants (Human Milk Oligosac- charides such as prebiotics, short-chain fructo-oligosaccharides and gum acacia), technology ( Propionibacterium freuden- reichii, a 2-in-1 bacterium for cheese production and related health benefits, a challenge test of the probiotics’ poten- tial to modulate immunity, a combination of omega-3s (from microalgae) and Lac- tobacillus reuteri, quality (flow cytometry, proposals to improve quality standards), regulation and consumption. Concerning this last aspect, please note (Elinor McCartney, Pen & Tec): “the data rejected by EFSA as concerns the claims related to probiotics may actually be convincing for health professionals”. Even if the practitioners are well informed and prescribe a specific probiotic to their patients, very often these latter will look for a cheaper alternative without further analysis - and therefore miss the opportu- nity to be counselled, while diminishing the News on Functional & Health Ingredients \ N°66 \ January - February - March 2019 \ ■